Indivior is a global pharmaceutical company focused on pioneering life-transforming treatments for substance use disorders and other serious mental health conditions.
Founded on a commitment to patient advocacy and science-based solutions, Indivior has played a pivotal role in reshaping the way society views and treats addiction. With a portfolio that includes innovative therapies for opioid use disorder (OUD), the company leads efforts to reduce stigma, expand access to treatment, and empower recovery.
Indivior’s work is grounded in the belief that addiction is a chronic, relapsing medical condition—one that demands a compassionate, clinical approach supported by ongoing research and education. Through partnerships and community engagement, Indivior continues to elevate standards of care for vulnerable populations, including justice-involved individuals affected by substance use.
